Be A Freedom Fighter · Bill Library

HR 10787 — Access to Medical Supplies Act

Freedom score: -2 (scale −10 to +10)

Sponsor: Rep. Murphy, Gregory F. [R-NC-3] · Latest action: Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. (2026-10-09)

Full text on GovInfo (introduced version) · Congress.gov · ← Bill Library index

Findings — 7 highlighted provisions

Each item below is one provision documented in the findings file. The same provision is highlighted in the full text underneath, with its section citation and criterion. Everything else on this page is plain, unreviewed bill text.

  1. Sec. 1 — Short title See in text ↓
  2. Sec. 2 · Government Power — Social Security Act §1847(a)(2)(A): Excludes urological and ostomy supplies from the Medicare competitive acquisition program only for supplies furnished Jan. 1, 2028–Dec. 31, 2032. This temporarily shelters a product category from competitive procurement rather than eliminating the entire competitive-bidding system See in text ↓
  3. Sec. 3, new §1847(g)(1)–(3) · Government Power — Requires a technical expert panel within 90 days of enactment, with at least 15 patient, clinical, supplier and industry stakeholders; recommendations within one year of creation and periodically afterward concerning inclusion of these supplies and access to medically appropriate brands See in text ↓
  4. Sec. 3, new §1847(g)(4)–(5) · Government Power — Requires the Secretary to implement competitive acquisition consistent with expert recommendations and publish panel minutes and documentation. Exact future conditions are contingent on the panel's recommendations and agency implementation See in text ↓
  5. Sec. 4, new §1847(h)(1)–(3) · Government Power — Requires a demonstration starting no later than three years after enactment, in no more than three states for twelve months, evaluating supply access and patient outcomes. Requires pre-project survey, early re-survey and panel consultation when patients cannot obtain prior products See in text ↓
  6. Sec. 5, new §1847(i)(1) · Government Power — Restricts contracted suppliers from influencing patients to switch the physician/patient-selected brand, expressly including persuasion, advice and unsolicited information about other brands. That is a regulation of supplier communications and marketing See in text ↓
  7. Sec. 5, new §1847(i)(2) · Government Power — Requires a beneficiary-access process for the same or clinically comparable product; if not available through a contract supplier, the individual may obtain supplies from a different or noncontract supplier. This expands a beneficiary's options while narrowing covered suppliers' freedom to market alternative brands See in text ↓

Full text (introduced version)

18 of 18 text blocks highlighted. Source: GovInfo, fetched cached.

[Congressional Bills 119th Congress] [From the U.S. Government Publishing Office] [H.R. 10787 Introduced in House (IH)] <DOC> 119th CONGRESS 2d Session H. R. 10787 To amend title XVIII of the Social Security Act to exclude urological and ostomy supplies from competitive acquisition programs under the Medicare program for 5 years, and for other purposes. _______________________________________________________________________ IN THE HOUSE OF REPRESENTATIVES October 9, 2026 Mr. Murphy (for himself and Mr. Schneider) introduced the following bill; which was referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned _______________________________________________________________________ A BILL To amend title XVIII of the Social Security Act to exclude urological and ostomy supplies from competitive acquisition programs under the Medicare program for 5 years, and for other purposes. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

Sec. 1 — Short title

This Act may be cited as the ``Access to Medical Supplies Act''.

SEC. 2. EXCLUDING UROLOGICAL AND OSTOMY SUPPLIES FROM COMPETITIVE ACQUISITION PROGRAMS UNDER THE MEDICARE PROGRAM FOR 5 YEARS.

Sec. 2 · Government Power — Social Security Act §1847(a)(2)(A): Excludes urological and ostomy supplies from the Medicare competitive acquisition program only for supplies furnished Jan. 1, 2028–Dec. 31, 2032. This temporarily shelters a product category from competitive procurement rather than eliminating the entire competitive-bidding system

Section 1847(a)(2)(A) of the Social Security Act (42 U.S.C. 1395w- 3(a)(2)(A)) is amended by inserting ``excluding urological and ostomy supplies (as defined in section 1861(s)(8) furnished on or after January 1, 2028, and before January 1, 2033),'' before ``and excluding drugs and biologicals.''.

SEC. 3. REQUIRING THE ESTABLISHMENT OF TECHNICAL EXPERT PANEL TO ANALYZE THE IMPACT OF INCLUDING UROLOGICAL AND OSTOMY SUPPLIES IN COMPETITIVE ACQUISITION PROGRAMS UNDER THE MEDICARE PROGRAM AND RECOMMEND CHANGES.

Sec. 3, new §1847(g)(1)–(3) · Government Power — Requires a technical expert panel within 90 days of enactment, with at least 15 patient, clinical, supplier and industry stakeholders; recommendations within one year of creation and periodically afterward concerning inclusion of these supplies and access to medically appropriate brands

Sec. 3, new §1847(g)(4)–(5) · Government Power — Requires the Secretary to implement competitive acquisition consistent with expert recommendations and publish panel minutes and documentation. Exact future conditions are contingent on the panel's recommendations and agency implementation

Section 1847 of the Social Security Act (42 U.S.C. 1395w-3) is amended by adding at the end the following new subsection:

Sec. 3, new §1847(g)(1)–(3) · Government Power — Requires a technical expert panel within 90 days of enactment, with at least 15 patient, clinical, supplier and industry stakeholders; recommendations within one year of creation and periodically afterward concerning inclusion of these supplies and access to medically appropriate brands

Sec. 3, new §1847(g)(4)–(5) · Government Power — Requires the Secretary to implement competitive acquisition consistent with expert recommendations and publish panel minutes and documentation. Exact future conditions are contingent on the panel's recommendations and agency implementation

``(g) Technical Expert Panel Review and Analyzation of the Impact of Including Urological and Ostomy Supplies in Competitive Acquisition Programs Under the Medicare Program.--

Sec. 3, new §1847(g)(1)–(3) · Government Power — Requires a technical expert panel within 90 days of enactment, with at least 15 patient, clinical, supplier and industry stakeholders; recommendations within one year of creation and periodically afterward concerning inclusion of these supplies and access to medically appropriate brands

Sec. 3, new §1847(g)(4)–(5) · Government Power — Requires the Secretary to implement competitive acquisition consistent with expert recommendations and publish panel minutes and documentation. Exact future conditions are contingent on the panel's recommendations and agency implementation

``(1) In general.--Not later than 90 days after the date of the enactment of this subsection, the Secretary (through use of a contractor or otherwise) shall establish a technical expert panel for purposes of reviewing the impact of including urological and ostomy supplies in the competitive acquisition programs under this section and recommending changes to such programs.

Sec. 3, new §1847(g)(1)–(3) · Government Power — Requires a technical expert panel within 90 days of enactment, with at least 15 patient, clinical, supplier and industry stakeholders; recommendations within one year of creation and periodically afterward concerning inclusion of these supplies and access to medically appropriate brands

Sec. 3, new §1847(g)(4)–(5) · Government Power — Requires the Secretary to implement competitive acquisition consistent with expert recommendations and publish panel minutes and documentation. Exact future conditions are contingent on the panel's recommendations and agency implementation

``(2) Review, assessment, and recommendations.--Not later than 1 year after the date the technical expert panel described in paragraph (1) is established (and periodically thereafter as the Secretary determines appropriate), the technical expert panel shall review stakeholder input and clinical literature and make recommendations to the Secretary with respect to including urological and ostomy supplies in the competitive acquisition programs under this section, including recommendations regarding how such programs, at a minimum-- ``(A) shall be administered in a manner in which the needs of patients, as determined by their physicians, are met through the widespread availability of specialized products to meet patient needs; ``(B) ensure that bids are submitted at a level that will allow beneficiaries to access the same range of products selected by ordering physicians prior to the implementation of the competitive acquisition program; ``(C) address other issues that the technical expert panel determines appropriate.

Sec. 3, new §1847(g)(1)–(3) · Government Power — Requires a technical expert panel within 90 days of enactment, with at least 15 patient, clinical, supplier and industry stakeholders; recommendations within one year of creation and periodically afterward concerning inclusion of these supplies and access to medically appropriate brands

Sec. 3, new §1847(g)(4)–(5) · Government Power — Requires the Secretary to implement competitive acquisition consistent with expert recommendations and publish panel minutes and documentation. Exact future conditions are contingent on the panel's recommendations and agency implementation

``(3) Membership.--In establishing the technical expert panel, the Secretary shall solicit recommendations from interested stakeholders. The technical expert panel shall be composed of a minimum of 15 individuals with relevant expertise and perspectives, including the following: ``(A) Home urological and ostomy supply patients and caregivers. ``(B) Experts with relevant clinical experience and expertise, including researchers and other clinicians. ``(C) Experts with subject matter expertise in reimbursement systems and medical necessity requirements under this title. ``(D) Experts in the supply of devices and services for urological and ostomy supplies. ``(E) Experts in the design, development, and manufacturing of urological and ostomy supplies.

Sec. 3, new §1847(g)(1)–(3) · Government Power — Requires a technical expert panel within 90 days of enactment, with at least 15 patient, clinical, supplier and industry stakeholders; recommendations within one year of creation and periodically afterward concerning inclusion of these supplies and access to medically appropriate brands

Sec. 3, new §1847(g)(4)–(5) · Government Power — Requires the Secretary to implement competitive acquisition consistent with expert recommendations and publish panel minutes and documentation. Exact future conditions are contingent on the panel's recommendations and agency implementation

``(4) Use of the recommendations by the secretary.--The Secretary shall implement the competitive acquisition program consistent with the recommendations described in paragraph (2).

Sec. 3, new §1847(g)(1)–(3) · Government Power — Requires a technical expert panel within 90 days of enactment, with at least 15 patient, clinical, supplier and industry stakeholders; recommendations within one year of creation and periodically afterward concerning inclusion of these supplies and access to medically appropriate brands

Sec. 3, new §1847(g)(4)–(5) · Government Power — Requires the Secretary to implement competitive acquisition consistent with expert recommendations and publish panel minutes and documentation. Exact future conditions are contingent on the panel's recommendations and agency implementation

``(5) Transparency.--The Secretary shall make the minutes of all meetings of the technical expert panel and all documentation relating to the formulation of recommendations described in paragraph (2) available to the public through the website of the Centers for Medicare & Medicaid Services.''.

SEC. 4. ESTABLISHMENT OF DEMONSTRATION PROJECT TO ASSESS INCLUSION OF UROLOGICAL AND OSTOMY SUPPLIES IN THE COMPETITIVE ACQUISITION PROGRAM.

Sec. 4, new §1847(h)(1)–(3) · Government Power — Requires a demonstration starting no later than three years after enactment, in no more than three states for twelve months, evaluating supply access and patient outcomes. Requires pre-project survey, early re-survey and panel consultation when patients cannot obtain prior products

Section 1847 of the Social Security Act (42 U.S.C. 1395w-3), as amended by section 3, is amended by adding at the end the following new subsection:

Sec. 4, new §1847(h)(1)–(3) · Government Power — Requires a demonstration starting no later than three years after enactment, in no more than three states for twelve months, evaluating supply access and patient outcomes. Requires pre-project survey, early re-survey and panel consultation when patients cannot obtain prior products

``(h) Establishment of Demonstration Project To Assess Inclusion of Urological and Ostomy Supplies in the Competitive Acquisition Programs.--

Sec. 4, new §1847(h)(1)–(3) · Government Power — Requires a demonstration starting no later than three years after enactment, in no more than three states for twelve months, evaluating supply access and patient outcomes. Requires pre-project survey, early re-survey and panel consultation when patients cannot obtain prior products

``(1) In general.--Not later than three years after the date of the enactment of this subsection, the Secretary shall conduct a demonstration project to test the inclusion of urological and ostomy supplies in the competitive acquisition program that assess the impact on beneficiary access and health outcomes. The Secretary shall use the results of the demonstration project to include such medical products in the competitive acquision program in a manner that-- ``(A) ensures individuals can access the same or clinically comparable medical supply products as determined by treating physicians; ``(B) ensures positive individual health outcomes; ``(C) ensures bidders can provide brand name medical supply products individuals used prior to the implementation of any demonstration or competitive acquisition program; and ``(D) includes recommendations from the technical expert panel described in subsection (g).

Sec. 4, new §1847(h)(1)–(3) · Government Power — Requires a demonstration starting no later than three years after enactment, in no more than three states for twelve months, evaluating supply access and patient outcomes. Requires pre-project survey, early re-survey and panel consultation when patients cannot obtain prior products

``(2) Demonstration project size and length.--The demonstration project shall be conducted in not more than 3 States and be conducted for 12 months.

Sec. 4, new §1847(h)(1)–(3) · Government Power — Requires a demonstration starting no later than three years after enactment, in no more than three states for twelve months, evaluating supply access and patient outcomes. Requires pre-project survey, early re-survey and panel consultation when patients cannot obtain prior products

``(3) Survey.-- ``(A) In general.--Prior to conducting the demonstration project, the Secretary shall survey a representative sample of individuals residing in the demonstration project bid area who used urological and ostomy supplies in the previous calendar year to determine which products such individuals have been utilizing. ``(B) Resurvey.--Not later than 3 months after the start of the demonstration project, the Secretary shall survey the same individuals described in subparagraph (A) to determine whether they are able to continue accessing the same medical supplies. If the individuals are not able to access the same medical supplies, the Secretary shall consult with the technical expert panel described in subsection (g) to provide recommended changes to address the access issue.''.

SEC. 5. PROHIBITION ON INFLUENCING AND INCENTIVIZING AND RIGHT TO PURCHASE THE SAME OR CLINICALLY COMPARABLE UROLOGICAL AND OSTOMY SUPPLIES.

Sec. 5, new §1847(i)(1) · Government Power — Restricts contracted suppliers from influencing patients to switch the physician/patient-selected brand, expressly including persuasion, advice and unsolicited information about other brands. That is a regulation of supplier communications and marketing

Sec. 5, new §1847(i)(2) · Government Power — Requires a beneficiary-access process for the same or clinically comparable product; if not available through a contract supplier, the individual may obtain supplies from a different or noncontract supplier. This expands a beneficiary's options while narrowing covered suppliers' freedom to market alternative brands

Section 1847 of the Social Security Act (42 U.S.C. 1395w-3), as amended by sections 3 and 4, is amended by adding at the end the following new subsection:

Sec. 5, new §1847(i)(1) · Government Power — Restricts contracted suppliers from influencing patients to switch the physician/patient-selected brand, expressly including persuasion, advice and unsolicited information about other brands. That is a regulation of supplier communications and marketing

Sec. 5, new §1847(i)(2) · Government Power — Requires a beneficiary-access process for the same or clinically comparable product; if not available through a contract supplier, the individual may obtain supplies from a different or noncontract supplier. This expands a beneficiary's options while narrowing covered suppliers' freedom to market alternative brands

``(i) Prohibition on Influencing and Incentivizing and Right To Purchase the Same or Clinically Comparable Urological and Ostomy Supplies.--

Sec. 5, new §1847(i)(1) · Government Power — Restricts contracted suppliers from influencing patients to switch the physician/patient-selected brand, expressly including persuasion, advice and unsolicited information about other brands. That is a regulation of supplier communications and marketing

Sec. 5, new §1847(i)(2) · Government Power — Requires a beneficiary-access process for the same or clinically comparable product; if not available through a contract supplier, the individual may obtain supplies from a different or noncontract supplier. This expands a beneficiary's options while narrowing covered suppliers' freedom to market alternative brands

``(1) In general.--A contract supplier may not attempt to influence or incentivize an individual to switch the brand of urological or ostomy supplies selected by the referring physician and individual, including by-- ``(A) persuading, pressuring, or advising the individual to switch; or ``(B) furnishing information about alternative brands to the individual where the individual has not requested such information.

Sec. 5, new §1847(i)(1) · Government Power — Restricts contracted suppliers from influencing patients to switch the physician/patient-selected brand, expressly including persuasion, advice and unsolicited information about other brands. That is a regulation of supplier communications and marketing

Sec. 5, new §1847(i)(2) · Government Power — Requires a beneficiary-access process for the same or clinically comparable product; if not available through a contract supplier, the individual may obtain supplies from a different or noncontract supplier. This expands a beneficiary's options while narrowing covered suppliers' freedom to market alternative brands

``(2) Individual right to purchase same or clinically comparable urological and ostomy supplies.-- ``(A) In general.--The Secretary shall establish a process to ensure that individuals receiving urological or ostomy supplies under a demonstration or other competitive acquisition program can access the same or clinically comparable urological or ostomy supplies as such individuals did prior to implementation of such demonstration or program. ``(B) Right to purchase.--The process established in subparagraph (A) shall specify that if the individual cannot access the same or clinically comparable urological or ostomy supplies as required under subparagraph (A), the individual has the right to receive such urological and ostomy supplies from another supplier, or a non-contract supplier.''. <all>

Findings source: bill-scores-v2-batch43-findings-2026-11-15.md. Highlights come only from that file; no finding, score, or provision was invented for this page.

What you can do

Contact your U.S. Representative and Senators about this bill.

Find your Representative Contact your Senators

Spot an error on this page? Report it.